May 2 (SeeNews) - Macedonian drug maker Alkaloid [MSE:ALK] said on Wednesday its consolidated net profit rose by an annual 7% to 246.8 million denars ($4.8 million/4 million euro) in the first three months of the year.
The company's sales revenue grew 4% year-on-year to 2.5 billion denars in the first quarter of 2018, Alkaloid said in an quarterly financial report, filed with the Skopje bourse.
Total costs increased 4% on the year to 2.24 billion denars in the period under review.
Alkaloid has three subsidiaries in Macedonia, as well as 14 subsidiaries and four representative offices abroad - in Serbia, Montenegro, Kosovo, Albania, Bosnia and Herzegovina, Croatia, Slovenia, Switzerland, Bulgaria, Turkey, Ukraine, Russia, and the US.
Alkaloid also operates a laboratory in Slovenia for the purposes of batch testing and release in the European Union.
(1 euro=61.41 denars)